Gastroenterology

When it comes to weight loss, Orbera Balloon fills a gap

Has the FDA Pivotal study uncovered a fundamental flaw in EndoBarrier? We may never know, but the trial ends regardless

New study supports the use of novel esophageal reflux therapy

New Bariatric Surgery device makes the most common weight loss procedure in U.S. more consistent and efficient

EndoBarrier Therapy avoids altering the anatomy by surgery, but does it do an equivalent job? Seems so

Endostim’s thinner, smaller new lower esophageal sphincter stimulating device promises an improved patient experience

The LINX® Gastro-esophageal reflux disease (GERD) therapy will be highlighted in several presentations at the Annual Society of American Gastrointestinal and Endoscopic Surgeons

Another storm-weathering exercise sees GI Dynamics reverse-splitting its stock on a 1:10 basis as it attempts to shore up its ailing share price

Newly published data suggest a Test-and-Treat approach to H. Pylori infection is viable and may carry several health benefits

Boston Scientific Corporation is to acquire Xlumena, Inc., developer of Endoscopic Ultrasound-guided transluminal drainage devices

Code represents important first step In process to gain coverage for incisionless procedures to treat the underlying cause of GERD

Followers of the EndoBarrier story will be wondering what happens next as the product’s maker is hit by more bad news

Enteromedics is celebrating approval of its novel neuroscience-based technology that it says enables safe, durable eeight loss

Innovative design of wireless, vitamin-sized capsule recognized for its profound impact on improving the standard-of-care for small bowel examinations

Cohera Medical, Inc. has received Priority Review Status Designation from the US FDA for its Sylys® Surgical Sealant

It doesn’t sound like GI Dynamics is in a good place at the moment as it loses staff in an effort to retrench.